Natural Capsules Holds EGM to Approve Preferential Issue and Warrants

HEALTHCAREBIOTECH
Whalesbook Corporate News Logo
AuthorKavya Nair|Published at:
Natural Capsules Holds EGM to Approve Preferential Issue and Warrants

Natural Capsules Limited successfully conducted its first Extraordinary General Meeting (EGM) of 2026, focusing on the proposed issuance of equity shares and convertible warrants on a preferential basis. The meeting, held via video conference, concluded after shareholder voting. Results are currently pending the Scrutinizer's report, which will be filed with stock exchanges shortly under SEBI guidelines.

Natural Capsules EGM Concludes for Preferential Issue

31 members attended the meeting held via video conferencing on September 09, 2026.
Two special resolutions regarding equity and warrant issuance were transacted during the session.

Reader Takeaway: Shareholders voted on preferential equity and warrants; outcome pending official Scrutinizer report to be filed soon.

What just happened

Natural Capsules Limited held its first Extraordinary General Meeting (EGM) for the year 2026. The meeting, conducted through video conferencing and other audio-visual means, was chaired by Independent Director Mr. Tekkar Yashwanth Prabhu. Managing Director Mr. Sunil L Mundra addressed members regarding the proposed capital raising plans.

Why this matters

The company is seeking shareholder approval for two significant items: the issuance of equity shares on a preferential basis and the issuance of warrants convertible into equity shares. Both proposals are presented as Special Resolutions, signaling a strategic effort by the company to bolster its capital base through preferential allotment.

Voting and Approval Process

The company implemented a dual-voting mechanism to ensure shareholder participation. Remote e-voting was accessible from September 04 to September 08, 2026. Additionally, participants at the virtual meeting were given a window to cast votes via the NSDL portal. Practicing Company Secretary Mr. Deepak Sadhu has been appointed as the Scrutinizer for the event.

What to track next

The final outcome of these resolutions is currently awaited. Natural Capsules is expected to submit the consolidated voting results, as verified by the Scrutinizer, to the stock exchanges. Investors should monitor upcoming BSE disclosures for the official results confirming the approval of the preferential issue and warrant conversion.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.